PURPOSE: The purpose was to explore operable lung cancer patient experiences with anexercise intervention from a longitudinal perspective according to patient motivation and patient perceived benefits and barriers of exercise. METHODS:Nineteen patients enrolled in anexercise intervention 2 weeks post-surgery participated in qualitative interviews at three time points. A criteria sampling strategy was applied. Ricoeur's phenomenological hermeneutical philosophy inspired the analysis. RESULTS: Patients initiated exercising median 15 days postoperative. Eight patients included in the interview study dropped out of the intervention due to side effects of chemotherapy (n = 3) and external circumstances (n = 5). The mean attendance rate for the eleven participants who completed the intervention was 82 %. No patients experienced severe adverse events. Motivation for participation included patients' expectations of physical benefits and the security of having professionals present. Patients experienced physical and emotional benefits and affirmed their social identity. Barriers were primarily related to side effects of chemotherapy. CONCLUSION: The exercise intervention was undertaken safely by operable lung cancer patients initiated 2 weeks after surgery. The intervention put the patients on track to a healthier lifestyle regarding physical activity and smoking. The study indicates that exercise initiated early in the treatment trajectory is beneficial for operable lung cancer patients and especially for those who were physically active and motivated pre-illness and who did not experience side effect of treatment.
RCT Entities:
PURPOSE: The purpose was to explore operable lung cancerpatient experiences with an exercise intervention from a longitudinal perspective according to patient motivation and patient perceived benefits and barriers of exercise. METHODS: Nineteen patients enrolled in an exercise intervention 2 weeks post-surgery participated in qualitative interviews at three time points. A criteria sampling strategy was applied. Ricoeur's phenomenological hermeneutical philosophy inspired the analysis. RESULTS:Patients initiated exercising median 15 days postoperative. Eight patients included in the interview study dropped out of the intervention due to side effects of chemotherapy (n = 3) and external circumstances (n = 5). The mean attendance rate for the eleven participants who completed the intervention was 82 %. No patients experienced severe adverse events. Motivation for participation included patients' expectations of physical benefits and the security of having professionals present. Patients experienced physical and emotional benefits and affirmed their social identity. Barriers were primarily related to side effects of chemotherapy. CONCLUSION: The exercise intervention was undertaken safely by operable lung cancerpatients initiated 2 weeks after surgery. The intervention put the patients on track to a healthier lifestyle regarding physical activity and smoking. The study indicates that exercise initiated early in the treatment trajectory is beneficial for operable lung cancerpatients and especially for those who were physically active and motivated pre-illness and who did not experience side effect of treatment.
Authors: Morten Quist; Mikael Rørth; Seppo Langer; Lee W Jones; Jørgen H Laursen; Helle Pappot; Karl Bang Christensen; Lis Adamsen Journal: Lung Cancer Date: 2011-08-03 Impact factor: 5.705
Authors: Linda Trinh; Nanette Mutrie; Anna M Campbell; Jennifer J Crawford; Kerry S Courneya Journal: Eur J Oncol Nurs Date: 2014-08-31 Impact factor: 2.398
Authors: Kerry S Courneya; Christine M Friedenreich; H Arthur Quinney; Anthony L A Fields; Lee W Jones; Jeffrey K H Vallance; Adrian S Fairey Journal: Ann Behav Med Date: 2005-04
Authors: Carol Ewing Garber; Bryan Blissmer; Michael R Deschenes; Barry A Franklin; Michael J Lamonte; I-Min Lee; David C Nieman; David P Swain Journal: Med Sci Sports Exerc Date: 2011-07 Impact factor: 5.411
Authors: Lee W Jones; Neil D Eves; Bercedis L Peterson; Jennifer Garst; Jeffrey Crawford; Miranda J West; Stephanie Mabe; David Harpole; William E Kraus; Pamela S Douglas Journal: Cancer Date: 2008-12-15 Impact factor: 6.860
Authors: Patricia M Kenny; Madeleine T King; Rosalie C Viney; Michael J Boyer; Christine A Pollicino; Jocelyn M McLean; Michael J Fulham; Brian C McCaughan Journal: J Clin Oncol Date: 2007-12-17 Impact factor: 44.544
Authors: Maike G Sweegers; Laurien M Buffart; Wouke M van Veldhuizen; Edwin Geleijn; Henk M W Verheul; Johannes Brug; Mai J M Chinapaw; Teatske M Altenburg Journal: Oncologist Date: 2018-11-13
Authors: Catherine L Granger; Bronwen Connolly; Linda Denehy; Nicholas Hart; Phillip Antippa; Kuan-Yin Lin; Selina M Parry Journal: Support Care Cancer Date: 2016-11-29 Impact factor: 3.603
Authors: Maja S Sommer; Karen Trier; Jette Vibe-Petersen; Malene Missel; Merete Christensen; Klaus R Larsen; Seppo W Langer; Carsten Hendriksen; Paul Frost Clementsen; Jesper H Pedersen; Henning Langberg Journal: Integr Cancer Ther Date: 2016-05-04 Impact factor: 3.279
Authors: Rikki Cannioto; John Lewis Etter; Michael J LaMonte; Andrew D Ray; Janine M Joseph; Emad Al Qassim; Kevin H Eng; Kirsten B Moysich Journal: Cancer Treat Res Commun Date: 2018
Authors: Maja S Sommer; Karen Trier; Jette Vibe-Petersen; Karl B Christensen; Malene Missel; Merete Christensen; Klaus R Larsen; Seppo W Langer; Carsten Hendriksen; Paul F Clementsen; Jesper H Pedersen; Henning Langberg Journal: Integr Cancer Ther Date: 2016-10-03 Impact factor: 3.279